Market revenue in 2021 | USD 7.4 million |
Market revenue in 2030 | USD 17.4 million |
Growth rate | 9.9% (CAGR from 2021 to 2030) |
Largest segment | Quadrivalent |
Fastest growing segment | Quadrivalent |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bivalent, Quadrivalent |
Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 63.51% in 2021. Horizon Databook has segmented the Turkey meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing risk of meningococcal infection and its high mortality rate is leading to a shift toward getting vaccinated against the disease. Moreover, growing initiatives to raise awareness about meningococcal infection and vaccination among pediatricians are expected to boost market growth.
The quadrivalent conjugate vaccine is available in the market in Turkey; however, it is not included in the country’s immunization program. The vaccine is recommended for people aged 50 & above traveling to Hajj and Umrah.
Moreover, Turkey monitors the progression of infection through its national surveillance network for managing the disease burden in the country. Surveillance data showed considerable spread of serogroup W meningococcal disease in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Turkey meningococcal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Turkey meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account